Beutel, Goodman & Co Ltd.
- SEC CIK
- 0001361974
- Latest filing
- Aug 12, 2026
EPRX holding history
Eupraxia Pharmaceuticals Inc. in every 13F filed by Beutel, Goodman & Co Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EPRX overviewAll 13F holders of EPRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,627,864
- Value
- $23.8M
- % of portfolio
- 0.2%
- Quarters held
- 4
- Since Q3 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,627,864 | $23.8M | 0.2% | −38,601−1.1% | Reduced | Holders |
| Q1 2026 | 3,666,465 | $26.4M | 0.2% | −42,908−1.2% | Reduced | Holders |
| Q4 2025 | 3,709,373 | $27.9M | 0.2% | −349,526−8.6% | Reduced | Holders |
| Q3 2025 | 4,058,899 | $23.9M | 0.1% | +4,058,899 | New | Holders |